80020-05-9

Usage

Uses

Used in Pharmaceutical Industry:
4-(PYRROLIDINE-1-CARBONYL)-BENZALDEHYDE is used as an intermediate in the synthesis of various drugs and organic compounds. Its unique structure allows it to be a key component in the development of new pharmaceuticals, potentially contributing to the creation of novel therapeutic agents.
Used in Organic Chemistry:
In the field of organic chemistry, 4-(PYRROLIDINE-1-CARBONYL)-BENZALDEHYDE serves as a valuable intermediate for the synthesis of a range of organic compounds. Its versatility in chemical reactions makes it a useful building block for the development of new chemical entities with diverse applications.
Potential Biological Activity:
4-(PYRROLIDINE-1-CARBONYL)-BENZALDEHYDE may possess biological activity, which could be explored through further research. Its potential applications in biological and medicinal fields may be uncovered as more is understood about its interactions with biological systems.
Further Research:
As a compound with potential applications in various fields, 4-(PYRROLIDINE-1-CARBONYL)-BENZALDEHYDE warrants additional research to fully understand its properties and uses. Ongoing studies may reveal new opportunities for its application in pharmaceuticals, organic chemistry, and other areas where its unique structure and properties can be leveraged.

Upstream product

• 123-75-1 pyrrolidine 
• 623-27-8 terephthalaldehyde, 
• 619-66-9 4-Carboxybenzaldehyde 
• 69897-42-3 4-formylbenzoic anhydride 
• 59746-40-6 pyrrolidin-1-yl(p-tolyl)methanone 

Downstream Products

• 407623-39-6 diethyl [2-(4-(4-chlorobenzoyl)-2-oxo-1-(4-(1-pyrrolidinecarbonyl)benzyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]-diazepin-8-yl)ethyl]phosphonate 

Relevant academic research and scientific papers

Visible-Light-Mediated Oxidative Amidation of Aldehydes by Using Magnetic CdS Quantum Dots as a Photocatalyst

A magnetic CdS quantum dot (Fe3O4/polydopamine (PDA)/CdS) was synthesized through a facile and convenient method from inexpensive starting materials. Characterization of the prepared catalyst was performed by means of FTIR spectrosco

Electrophilic Activation of Carboxylic Anhydrides for Nucleophilic Acylation Reactions

Nucleophilic acylation of symmetrical carboxylic anhydrides has inherited limitation of reaction efficiency along with relatively poor reactivity. Traditionally, one equivalent carboxylic acid is generated during nucleophilic acylation of a symmetrical anhydride, which always limits the yield of final product to 50percent or less. This is a major drawback, which discourages the use of anhydrides for laboratory or industrial applications. Electrophilic activation of carboxylic anhydride using methanesulfonyl chloride is found to be an efficient method for nucleophilic acylation, which increases product yield by restricting the formation of corresponding acid as a side product. The developed protocol found to be a mild and high yielding methodology for one-pot nucleophilic acylation of carboxylic anhydrides with several type of N- and S-nucleophiles demonstrating appreciable functional group tolerance.

Development of a Rhodium(II)-Catalyzed Chemoselective C(sp3)-H Oxygenation

We report the first example of RhII-catalyzed chemoselective double C(sp3)-H oxygenation, which can directly transform various toluene derivatives into highly valuable aromatic aldehydes with great chemoselectivity and practicality. The critical combination of catalyst Rh(OAc)2, oxidant Selectfluor, and solvents of TFA/TFAA promises the successful delivery of the oxidation with satisfactory yields. A possible mechanism involving a unique carbene-Rh complex is proposed, and has been supported by both experiments and theoretical calculations.

Gold-catalyzed amide synthesis from aldehydes and amines in aqueous medium

An efficient gold-catalyzed amide synthesis from aldehydes and amines in aqueous medium under mild reaction conditions has been developed.

Benzodiazepine derivatives

The present invention provides benzodiazepine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of inhibiting activated blood-coagulation factor X. These compounds are usable as agents for treating various diseases concerned with the activated blood-coagulation factor X.